Report Detail

Request for Sample of this report

Other Global Organoid Biobank Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4559970
    • |
  • 09 October, 2023
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Organoid Biobank market size was valued at USD 124.5 million in 2022 and is forecast to a readjusted size of USD 389.7 million by 2029 with a CAGR of 17.7% during review period.
Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
The Global Info Research report includes an overview of the development of the Organoid Biobank industry chain, the market status of Biopharmaceutical Companies (Tissue Derived Organoids, Pluripotent Stem Cell-derived Organoids), Contract Research Organizations (Tissue Derived Organoids, Pluripotent Stem Cell-derived Organoids), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Organoid Biobank.
Regionally, the report analyzes the Organoid Biobank markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Organoid Biobank market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Organoid Biobank market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Organoid Biobank industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Tissue Derived Organoids, Pluripotent Stem Cell-derived Organoids).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Organoid Biobank market.
Regional Analysis: The report involves examining the Organoid Biobank market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Organoid Biobank market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Organoid Biobank:
Company Analysis: Report covers individual Organoid Biobank players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Organoid Biobank This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biopharmaceutical Companies, Contract Research Organizations).
Technology Analysis: Report covers specific technologies relevant to Organoid Biobank. It assesses the current state, advancements, and potential future developments in Organoid Biobank areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Organoid Biobank market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Organoid Biobank market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids
Market segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Market segment by players, this report covers
FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Organoid Biobank product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Organoid Biobank, with revenue, gross margin and global market share of Organoid Biobank from 2018 to 2023.
Chapter 3, the Organoid Biobank competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Organoid Biobank market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Organoid Biobank.
Chapter 13, to describe Organoid Biobank research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Organoid Biobank
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Organoid Biobank by Type
    • 1.3.1 Overview: Global Organoid Biobank Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Organoid Biobank Consumption Value Market Share by Type in 2022
    • 1.3.3 Tissue Derived Organoids
    • 1.3.4 Pluripotent Stem Cell-derived Organoids
  • 1.4 Global Organoid Biobank Market by Application
    • 1.4.1 Overview: Global Organoid Biobank Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Biopharmaceutical Companies
    • 1.4.3 Contract Research Organizations
    • 1.4.4 Academics and Research Institutes
  • 1.5 Global Organoid Biobank Market Size & Forecast
  • 1.6 Global Organoid Biobank Market Size and Forecast by Region
    • 1.6.1 Global Organoid Biobank Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Organoid Biobank Market Size by Region, (2018-2029)
    • 1.6.3 North America Organoid Biobank Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Organoid Biobank Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Organoid Biobank Market Size and Prospect (2018-2029)
    • 1.6.6 South America Organoid Biobank Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Organoid Biobank Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 FRANKFURT CANCER INSTITUTE
    • 2.1.1 FRANKFURT CANCER INSTITUTE Details
    • 2.1.2 FRANKFURT CANCER INSTITUTE Major Business
    • 2.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Product and Solutions
    • 2.1.4 FRANKFURT CANCER INSTITUTE Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 FRANKFURT CANCER INSTITUTE Recent Developments and Future Plans
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Organoid Biobank Product and Solutions
    • 2.2.4 Merck Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Merck Recent Developments and Future Plans
  • 2.3 Crown Bioscience
    • 2.3.1 Crown Bioscience Details
    • 2.3.2 Crown Bioscience Major Business
    • 2.3.3 Crown Bioscience Organoid Biobank Product and Solutions
    • 2.3.4 Crown Bioscience Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Crown Bioscience Recent Developments and Future Plans
  • 2.4 HUB Organoids
    • 2.4.1 HUB Organoids Details
    • 2.4.2 HUB Organoids Major Business
    • 2.4.3 HUB Organoids Organoid Biobank Product and Solutions
    • 2.4.4 HUB Organoids Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 HUB Organoids Recent Developments and Future Plans
  • 2.5 Cancer Research UK Convergence Science Centre
    • 2.5.1 Cancer Research UK Convergence Science Centre Details
    • 2.5.2 Cancer Research UK Convergence Science Centre Major Business
    • 2.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Product and Solutions
    • 2.5.4 Cancer Research UK Convergence Science Centre Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cancer Research UK Convergence Science Centre Recent Developments and Future Plans
  • 2.6 Thermo Fisher Scientific
    • 2.6.1 Thermo Fisher Scientific Details
    • 2.6.2 Thermo Fisher Scientific Major Business
    • 2.6.3 Thermo Fisher Scientific Organoid Biobank Product and Solutions
    • 2.6.4 Thermo Fisher Scientific Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.7 Corning
    • 2.7.1 Corning Details
    • 2.7.2 Corning Major Business
    • 2.7.3 Corning Organoid Biobank Product and Solutions
    • 2.7.4 Corning Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Corning Recent Developments and Future Plans
  • 2.8 STEMCELL Technologies
    • 2.8.1 STEMCELL Technologies Details
    • 2.8.2 STEMCELL Technologies Major Business
    • 2.8.3 STEMCELL Technologies Organoid Biobank Product and Solutions
    • 2.8.4 STEMCELL Technologies Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 STEMCELL Technologies Recent Developments and Future Plans
  • 2.9 Lonza
    • 2.9.1 Lonza Details
    • 2.9.2 Lonza Major Business
    • 2.9.3 Lonza Organoid Biobank Product and Solutions
    • 2.9.4 Lonza Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Lonza Recent Developments and Future Plans
  • 2.10 Prellis Biologics
    • 2.10.1 Prellis Biologics Details
    • 2.10.2 Prellis Biologics Major Business
    • 2.10.3 Prellis Biologics Organoid Biobank Product and Solutions
    • 2.10.4 Prellis Biologics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Prellis Biologics Recent Developments and Future Plans
  • 2.11 Amsbio
    • 2.11.1 Amsbio Details
    • 2.11.2 Amsbio Major Business
    • 2.11.3 Amsbio Organoid Biobank Product and Solutions
    • 2.11.4 Amsbio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Amsbio Recent Developments and Future Plans
  • 2.12 Cellesce
    • 2.12.1 Cellesce Details
    • 2.12.2 Cellesce Major Business
    • 2.12.3 Cellesce Organoid Biobank Product and Solutions
    • 2.12.4 Cellesce Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Cellesce Recent Developments and Future Plans
  • 2.13 DefiniGEN
    • 2.13.1 DefiniGEN Details
    • 2.13.2 DefiniGEN Major Business
    • 2.13.3 DefiniGEN Organoid Biobank Product and Solutions
    • 2.13.4 DefiniGEN Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 DefiniGEN Recent Developments and Future Plans
  • 2.14 3Dnamics Inc.
    • 2.14.1 3Dnamics Inc. Details
    • 2.14.2 3Dnamics Inc. Major Business
    • 2.14.3 3Dnamics Inc. Organoid Biobank Product and Solutions
    • 2.14.4 3Dnamics Inc. Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 3Dnamics Inc. Recent Developments and Future Plans
  • 2.15 Organoid Therapeutics
    • 2.15.1 Organoid Therapeutics Details
    • 2.15.2 Organoid Therapeutics Major Business
    • 2.15.3 Organoid Therapeutics Organoid Biobank Product and Solutions
    • 2.15.4 Organoid Therapeutics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Organoid Therapeutics Recent Developments and Future Plans
  • 2.16 InSphero
    • 2.16.1 InSphero Details
    • 2.16.2 InSphero Major Business
    • 2.16.3 InSphero Organoid Biobank Product and Solutions
    • 2.16.4 InSphero Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 InSphero Recent Developments and Future Plans
  • 2.17 AIVITA Biomedical
    • 2.17.1 AIVITA Biomedical Details
    • 2.17.2 AIVITA Biomedical Major Business
    • 2.17.3 AIVITA Biomedical Organoid Biobank Product and Solutions
    • 2.17.4 AIVITA Biomedical Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 AIVITA Biomedical Recent Developments and Future Plans
  • 2.18 JangoBio
    • 2.18.1 JangoBio Details
    • 2.18.2 JangoBio Major Business
    • 2.18.3 JangoBio Organoid Biobank Product and Solutions
    • 2.18.4 JangoBio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 JangoBio Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Organoid Biobank Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Organoid Biobank by Company Revenue
    • 3.2.2 Top 3 Organoid Biobank Players Market Share in 2022
    • 3.2.3 Top 6 Organoid Biobank Players Market Share in 2022
  • 3.3 Organoid Biobank Market: Overall Company Footprint Analysis
    • 3.3.1 Organoid Biobank Market: Region Footprint
    • 3.3.2 Organoid Biobank Market: Company Product Type Footprint
    • 3.3.3 Organoid Biobank Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Organoid Biobank Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Organoid Biobank Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Organoid Biobank Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Organoid Biobank Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Organoid Biobank Consumption Value by Type (2018-2029)
  • 6.2 North America Organoid Biobank Consumption Value by Application (2018-2029)
  • 6.3 North America Organoid Biobank Market Size by Country
    • 6.3.1 North America Organoid Biobank Consumption Value by Country (2018-2029)
    • 6.3.2 United States Organoid Biobank Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Organoid Biobank Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Organoid Biobank Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Organoid Biobank Consumption Value by Type (2018-2029)
  • 7.2 Europe Organoid Biobank Consumption Value by Application (2018-2029)
  • 7.3 Europe Organoid Biobank Market Size by Country
    • 7.3.1 Europe Organoid Biobank Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Organoid Biobank Market Size and Forecast (2018-2029)
    • 7.3.3 France Organoid Biobank Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Organoid Biobank Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Organoid Biobank Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Organoid Biobank Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Organoid Biobank Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Organoid Biobank Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Organoid Biobank Market Size by Region
    • 8.3.1 Asia-Pacific Organoid Biobank Consumption Value by Region (2018-2029)
    • 8.3.2 China Organoid Biobank Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Organoid Biobank Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Organoid Biobank Market Size and Forecast (2018-2029)
    • 8.3.5 India Organoid Biobank Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Organoid Biobank Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Organoid Biobank Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Organoid Biobank Consumption Value by Type (2018-2029)
  • 9.2 South America Organoid Biobank Consumption Value by Application (2018-2029)
  • 9.3 South America Organoid Biobank Market Size by Country
    • 9.3.1 South America Organoid Biobank Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Organoid Biobank Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Organoid Biobank Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Organoid Biobank Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Organoid Biobank Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Organoid Biobank Market Size by Country
    • 10.3.1 Middle East & Africa Organoid Biobank Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Organoid Biobank Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Organoid Biobank Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Organoid Biobank Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Organoid Biobank Market Drivers
  • 11.2 Organoid Biobank Market Restraints
  • 11.3 Organoid Biobank Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Organoid Biobank Industry Chain
  • 12.2 Organoid Biobank Upstream Analysis
  • 12.3 Organoid Biobank Midstream Analysis
  • 12.4 Organoid Biobank Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Organoid Biobank. Industry analysis & Market Report on Organoid Biobank is a syndicated market report, published as Global Organoid Biobank Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Organoid Biobank market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,742.24
    		4,113.36
    		5,484.48
    		3,201.60
    		4,802.40
    		6,403.20
    		541,488.00
    		812,232.00
    		1,082,976.00
    		290,162.40
    		435,243.60
    		580,324.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo